MoonLake Immunotherapeutics (MLTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.156 | -3.908 | -66.957 | -14.611 |
Return on Equity (%) | -3.64 | 441.282 | -209.069 | -15.141 |
Return on Invested Capital (%) | 8.376 | 94.892 | -211.128 | -18.896 |
Operating Margin (%) | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.799 | 3.645 | 0.493 | 3.232 |
Earnings Per Share | -0.003 | -0.153 | -0.463 | -0.277 |
Cash Per Share | 0.045 | 0.023 | 0.283 | 2.839 |
Working Capital Per Share | 0.05 | -0.104 | 0.494 | 3.173 |
Operating Profit Per Share | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.003 | -0.153 | -0.462 | -0.277 |
EBITDA Per Share | -0.003 | -0.153 | -0.462 | -0.277 |
Free Cash Flow Per Share | -0.003 | -0.153 | -0.463 | -0.276 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 11,93M | 11,93M | 38,98M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | 38,98M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,33B |
Ratio cours/bénéfice | -75,63 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 7,39 |
Ratio prix/valeur comptable | 6,49 |
Rendement de dividende | - |
Actions en circulation | 63,91M |
Volume moyen (1 semaine) | 270,9k |
Volume moyen (1 mois) | 187,1k |
Variation sur 52 semaines | -13,91% |
Plus haut sur 52 semaines | 64,98 |
Plus bas sur 52 semaines | 37,55 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales